Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Morepen Laboratories Ltd

Pharmaceuticals & Biotechnology | Small Cap

Morepen Laboratories Ltd Health Insights
Health Score : 7.12Health Score : 7.12

Morepen Laboratories Ltd demonstrates a mixed financial performance. The company shows exceptional solvency and growth, driven by minimal debt and robust expansion in revenue, profits, and assets. Profitability is also a strong point, with impressive returns on capital, equity, and assets, alongside healthy margins. However, efficiency in asset utilization is a concern, as indicated by lower turnover ratios and longer inventory holding periods. The company's liquidity is reasonable, though there are some weaknesses noted in cash flow management. Furthermore, financial metrics such as earnings per share, book value, and capital expenditure need attention. Overall, Morepen Laboratories exhibits solid financial health, but improvements in operational efficiency and financial management could further enhance its performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Morepen Laboratories Ltd Health Insights
Health Score : 7.12Health Score : 7.12

Morepen Laboratories Ltd demonstrates a mixed financial performance. The company shows exceptional solvency and growth, driven by minimal debt and robust expansion in revenue, profits, and assets. Profitability is also a strong point, with impressive returns on capital, equity, and assets, alongside healthy margins. However, efficiency in asset utilization is a concern, as indicated by lower turnover ratios and longer inventory holding periods. The company's liquidity is reasonable, though there are some weaknesses noted in cash flow management. Furthermore, financial metrics such as earnings per share, book value, and capital expenditure need attention. Overall, Morepen Laboratories exhibits solid financial health, but improvements in operational efficiency and financial management could further enhance its performance.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

40.91

Neutral

Industry Median

28.62

Neutral
Neutral

Small Cap Median

27.17

Neutral

P/E RATIO

28.61

P/B RATIO

2.17

Undervalued

Industry Median

3.17

Undervalued
Neutral

Small Cap Median

2.62

Neutral

P/S RATIO

1.46

Undervalued

Industry Median

3.42

Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

15.78

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹49.5 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company demonstrates excellent growth across various metrics. Revenue, operating profit, EPS, asset, and net income growth rates are all strong, reflecting the company's robust expansion and increasing profitability. This indicates the company is effectively capitalizing on market opportunities and generating significant value for its stakeholders. The consistent positive growth trend suggests a promising outlook for future performance.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate30.22-8.3419.187.22-0.33
Operating Profit Growth Rate15.13-41.6198.759.43-27.59
Earnings Per Share (EPS) Growth-1.39-64.32147.3714.36-19.53
Asset Growth Rate24.713.7416.4937.518.89
Net Income Growth Rate5.15-61.76148.7221.65-18.64
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.40

The company's financial ratios present some challenges. Adjusted EPS, cash EPS, and book value per share are below expectations, indicating potential areas for improvement in earnings quality and asset valuation. Dividend per share is also low, and capital expenditures are high, suggesting a need to optimize investment strategies and enhance shareholder returns. Addressing these issues could improve the company's financial performance and investor perception.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)2.120.761.92.151.38
Cash Earnings Per Share (Cash EPS)2.711.312.552.672.4
Book Value Per Share12.0614.7616.6121.0422.67
Dividend Per Share (DPS)0000.190.21
Capital Expenditures (CapEx)674681214160
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company exhibits excellent profitability ratios, reflecting its ability to generate profits from its operations and investments. Gross profit margin, ROCE, ROE, ROA, operating margin, and net margin are all strong, indicating efficient cost management and effective revenue generation. This demonstrates the company's capacity to deliver superior returns to its stakeholders and maintain a competitive edge in the industry.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin7.053.677.4684.98
Return on Capital Employed (ROCE)23817158
Return on Equity (ROE)17.625.1811.4510.27.7
Return on Assets (ROA)12.87.2112.39.796.51
Operating Margin8.865.649.419.66.98
Net Margin6.592.755.746.515.32
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The company's efficiency in utilizing its assets shows mixed performance. While inventory and receivables turnover are at an average level, the fixed asset and capital turnover ratios reveal potential inefficiencies. Longer days sales in inventory and receivable days suggest challenges in managing working capital effectively. These factors indicate that the company may need to optimize its asset utilization to improve overall operational efficiency.

WeakFixed Asset Turnover RatioWeak
AverageInventory Turnover RatioAverage
AverageReceivables Turnover RatioAverage
AverageDays Sales in Inventory RatioAverage
WeakReceivable DaysWeak
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio6.145.315.53.713.52
Inventory Turnover Ratio6.385.416.556.076
Receivables Turnover Ratio7.155.525.755.585.49
Days Sales in Inventory Ratio57.2167.4755.7360.1360.83
Receivable Days51.0566.1263.4865.4166.48
Capital Turnover Ratio2.671.881.991.51.3
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company exhibits excellent coverage ratios, indicating a strong ability to meet its interest and dividend obligations. The interest coverage ratio demonstrates that the company can comfortably cover its interest expenses with its earnings. The equity dividend coverage ratio shows a solid capacity to pay dividends to equity shareholders. These factors suggest financial stability and reduced risk for investors.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio-17.142934.7520.388.5
Equity Dividend Coverage Ratio11.118.33
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits excellent solvency, with minimal debt and a strong equity base. The debt and debt-to-equity ratios indicate very low levels of financial leverage, reducing the risk of financial distress. A high equity ratio further supports this, demonstrating that the company is primarily financed by equity rather than debt. This provides a stable financial foundation and greater flexibility in navigating economic uncertainties.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0000.040.11
Debt to Equity Ratio0000.040.12
Equity Ratio1110.960.89
Debt To Asset Ratio0000.030.08
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 7.04

The company's liquidity position shows mixed results. Its ability to meet short-term obligations is generally adequate. The quick ratio suggests a strong capacity to cover immediate liabilities with its most liquid assets. However, cash and operating cash flow ratios indicate some challenges in maintaining sufficient cash reserves and generating positive cash flows from operations. This could affect the company's flexibility in handling unforeseen expenses or investment opportunities.

GoodCurrent RatioGood
ExcellentQuick RatioExcellent
WeakCash RatioWeak
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.642.322.172.062.35
Quick Ratio1.081.681.61.531.85
Cash Ratio0.090.160.120.090.13
Operating Cash Flow Ratio-0.12-0.260.160.060.06
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 17 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
3Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
4Lincoln Pharmaceuticals Ltd7.3114.01Neutral98.0043.8888.00
5RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
6Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
7Alembic Ltd7.067.28Undervalued90.004.85317.00
8Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
9Hester Biosciences Ltd6.5431.74Neutral87.0061.2457.00
10Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
11SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
12Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
13Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
14IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
15Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
16Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
Management Assessment Summary
OrangeBalanced Management

The management of Morepen Laboratories presents a mixed assessment. The company has demonstrated sales and profit growth over the past decade. However, there's a decline in operating profit margin (OPM) and return on equity (ROE) in recent years. The promoter holding remains relatively stable, indicating continued confidence from the company's leadership. Overall, while the company shows potential, the recent financial trends suggest areas needing focused attention and improvement.

Category Metric Value Assessment
PROS Compounded Sales Growth (10 Years) 16% Revenue Expansion
Compounded Profit Growth (10 Years) 49% Profit growth
CONS Recent OPM Decline 9% (Mar 2025) Operational Efficiency
Recent ROE Decline 12% (Mar 2025) Shareholder Returns
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
AverageStrategic & Operational IndicatorsAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Morepen Laboratories is rated Orange, indicating moderate risk. The company exhibits segment performance volatility reflected in fluctuating quarterly sales and profit growth. Foreign exchange or interest rate exposure are not explicitly detailed, but the presence of borrowings and international sales suggests potential exposure. Overall, the identified risks suggest a need for cautious monitoring and proactive risk management strategies.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1050.30Bearish
  3. SMA 2050.97Bearish
  4. SMA 5050.61Bearish
  5. EMA 1050.23Bearish
  6. EMA 2050.64Bearish
  7. EMA 5050.20Bearish
  8. DEMA 1049.67Bullish
  9. DEMA 2050.28Bearish
  10. DEMA 5051.68Bearish
  11. TEMA 1049.52Bullish
  12. TEMA 2049.57Bullish
  13. TEMA 5051.31Bearish
  14. MACD-0.34Bearish
  15. ADX30.91Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI36.50Neutral
  3. CCI-115.07Oversold
  4. ROC 9-1.97Bearish
  5. ROC 14-3.19Bearish
  6. ROC 25-4.51Bearish
  7. Stoch K21.65Neutral
  8. Stoch D13.32Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper52.63Neutral
  3. BB Middle50.97Neutral
  4. BB Lower49.30Neutral
  5. ATR0.75Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI34.03Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1050.70Bearish
  3. SMA 2051.38Bearish
  4. SMA 5048.54Bullish
  5. EMA 1050.49Bearish
  6. EMA 2050.52Bearish
  7. EMA 5049.00Bullish
  8. DEMA 1050.01Bearish
  9. DEMA 2051.12Bearish
  10. DEMA 5051.47Bearish
  11. TEMA 1049.48Bullish
  12. TEMA 2050.34Bearish
  13. TEMA 5052.04Bearish
  14. MACD0.30Bearish
  15. ADX29.39Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI45.50Neutral
  3. CCI-135.18Oversold
  4. ROC 9-3.64Bearish
  5. ROC 14-4.14Bearish
  6. ROC 255.34Bullish
  7. Stoch K17.87Oversold
  8. Stoch D12.54Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper53.20Neutral
  3. BB Middle51.37Neutral
  4. BB Lower49.55Neutral
  5. ATR1.02Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI35.75Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1051.35Bearish
  3. SMA 2049.55Bullish
  4. SMA 5045.95Bullish
  5. EMA 1050.49Bearish
  6. EMA 2049.51Bullish
  7. EMA 5046.97Bullish
  8. DEMA 1051.02Bearish
  9. DEMA 2051.56Bearish
  10. DEMA 5050.17Bearish
  11. TEMA 1050.31Bearish
  12. TEMA 2051.72Bearish
  13. TEMA 50N/AN/A
  14. MACD1.45Bearish
  15. ADX38.53Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI54.70Neutral
  3. CCI-3.28Neutral
  4. ROC 9-4.20Bearish
  5. ROC 141.16Bullish
  6. ROC 2511.42Bullish
  7. Stoch K48.41Neutral
  8. Stoch D56.73Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper54.74Neutral
  3. BB Middle49.55Neutral
  4. BB Lower44.36Neutral
  5. ATR1.71Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI51.83Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1049.50Bearish
  3. SMA 2046.87Bullish
  4. SMA 5044.09Bullish
  5. SMA 10041.33Bullish
  6. SMA 20043.49Bullish
  7. EMA 1049.47Bullish
  8. EMA 2047.65Bullish
  9. EMA 5044.78Bullish
  10. EMA 10043.48Bullish
  11. EMA 20045.19Bullish
  12. DEMA 1051.39Bearish
  13. DEMA 2050.47Bearish
  14. DEMA 5047.71Bullish
  15. DEMA 10043.62Bullish
  16. DEMA 20040.32Bullish
  17. TEMA 1051.50Bearish
  18. TEMA 2051.48Bearish
  19. TEMA 5049.86Bearish
  20. TEMA 10047.05Bullish
  21. TEMA 20040.30Bullish
  22. MACD2.20Bullish
  23. ADX30.58Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI58.23Neutral
  3. CCI65.04Neutral
  4. ROC 146.43Bullish
  5. ROC 2515.09Bullish
  6. Stoch K73.38Neutral
  7. Stoch D80.83Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper53.62Neutral
  3. BB Middle46.87Neutral
  4. BB Lower40.12Neutral
  5. ATR2.62High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI77.40Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2040.81Bullish
  3. SMA 5045.26Bullish
  4. EMA 2042.59Bullish
  5. EMA 5045.55Bullish
  6. DEMA 2042.55Bullish
  7. DEMA 5039.95Bullish
  8. TEMA 2045.36Bullish
  9. TEMA 5037.85Bullish
  10. MACD0.38Bullish
  11. ADX17.78Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI56.80Neutral
  3. CCI30.96Neutral
  4. ROC 1425.96Bullish
  5. ROC 2522.69Bullish
  6. Stoch K73.55Neutral
  7. Stoch D66.22Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper47.71Overbought
  3. BB Middle40.81Neutral
  4. BB Lower33.92Neutral
  5. ATR4.71High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI78.03Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 639.89Bullish
  3. SMA 1245.42Bearish
  4. SMA 2456.12Bearish
  5. EMA 641.74Bullish
  6. EMA 1245.11Bearish
  7. EMA 2448.34Bearish
  8. DEMA 639.52Bullish
  9. DEMA 1239.41Bullish
  10. DEMA 2446.59Bearish
  11. TEMA 641.15Bullish
  12. TEMA 1236.81Bullish
  13. TEMA 2440.79Bullish
  14. MACD1.55Bearish
  15. ADX16.73Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI49.36Neutral
  3. CCI-17.48Neutral
  4. ROC 25-13.61Bearish
  5. ROC 5018.30Bullish
  6. Stoch K19.56Oversold
  7. Stoch D42.19Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper81.03Neutral
  3. BB Middle53.31Neutral
  4. BB Lower25.59Neutral
  5. ATR11.41Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI68.28Neutral